Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,306 | 72,700 | 74,169 | 76,928 | 86,731 |
| Receivables | 1,276 | 509 | 662 | 237 | 562 |
| TOTAL | $67,582 | $73,209 | $74,831 | $77,165 | $87,293 |
| Non-Current Assets | |||||
| PPE Net | 1,388 | 318 | 359 | 400 | 467 |
| Intangibles | 622 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 199 | 216 | 244 | 53 | 54 |
| TOTAL | $2,209 | $534 | $603 | $453 | $521 |
| Total Assets | $69,791 | $73,743 | $75,434 | $77,618 | $87,814 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,300 | 958 | 3,396 | 4,618 | 10,749 |
| TOTAL | $2,565 | $1,159 | $3,596 | $4,627 | $10,749 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 205 | 255 | 296 | 0 | 343 |
| TOTAL | $351 | $255 | $296 | $319 | $343 |
| Total Liabilities | $2,916 | $1,414 | $3,892 | $4,946 | $11,092 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,917 | 1,177 | 1,177 | 1,177 | 1,177 |
| Retained earnings | -291,428 | -232,296 | -232,295 | -230,087 | -225,200 |
| TOTAL | $66,875 | $72,329 | $71,542 | $72,672 | $76,722 |
| Total Liabilities And Equity | $69,791 | $73,743 | $75,434 | $77,618 | $87,814 |